Close

Maxim Group Downgrades Adamis Pharmaceuticals (ADMP) to Hold, After Comapny Receives Complete Response Letter

November 16, 2020 11:29 AM EST Send to a Friend
Maxim Group analyst Jason McCarthy downgraded Adamis Pharmaceuticals (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login